View in EDS

Target 2035 - an update on private sector contributions.

Saved in:
Bibliographic Details
Title: Target 2035 - an update on private sector contributions.
Authors: Ackloo S; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca., Antolin AA; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL) L'Hospitalet del Llobregat Barcelona Catalonia Spain aantolin@idibell.cat., Bartolome JM; A Division of Janssen-Cilag S.A., Janssen Research and Development Toledo Spain jbartolo@its.jnj.com JLlaveri@ITS.JNJ.com., Beck H; Research and Development, Bayer AG, Pharmaceuticals 42103 Wuppertal Germany hartmut.beck@bayer.com jan.dreher@bayer.com alexander.hillisch@bayer.com., Bullock A; Center for Medicines Discovery, Old Road Campus, University of Oxford Roosevelt Drive, Headington Oxford OX3 7DQ UK alex.bullock@cmd.ox.ac.uk jon.elkins@cmd.ox.ac.uk., Betz UAK; Merck KGaA Darmstadt Germany ulrich.betz@merckgroup.com Sven.Lindemann@merckgroup.com., Böttcher J; Boehringer Ingelheim RCV GmbH & Co KG Vienna Austria jark.boettcher@boehringer-ingelheim.com., Brown PJ; Structural Genomics Consortium, University of North Carolina at Chapel Hill USA peter.brown@unc.edu., Chaturvedi M; Boehringer Ingelheim International Binger Str. 173 D-55216 Ingelheim Germany menorca.chaturvedi@boehringer-ingelheim.com markus.koester@boehringer-ingelheim.com oliver.kraemer@boehringer-ingelheim.com., Crisp A; Division of Cancer Therapeutics, The Institute of Cancer Research London SM2 5NG UK Alisa.crisp@icr.ac.uk., Daniels D; Foghorn Therapeutics 500 Technology Square, Suite 700 Cambridge MA 02139 USA DDaniels@foghorntx.com., Dreher J; Research and Development, Bayer AG, Pharmaceuticals 42103 Wuppertal Germany hartmut.beck@bayer.com jan.dreher@bayer.com alexander.hillisch@bayer.com., Edfeldt K; Structural Genomics Consortium, Department of Medicine, Karolinska University Hospital and Karolinska Institutet Stockholm Sweden kristina.edfeldt@ki.se michael.sundstrom@ki.se., Edwards AM; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca., Egner U; Nuvisan Innovation Campus Berlin GmbH Müllerstraße 178 13353 Berlin Germany egner.target2035@web.de anke.mueller-fahrnow@nuvisan.com., Elkins J; Center for Medicines Discovery, Old Road Campus, University of Oxford Roosevelt Drive, Headington Oxford OX3 7DQ UK alex.bullock@cmd.ox.ac.uk jon.elkins@cmd.ox.ac.uk., Fischer C; Discovery Chemistry, Merck & Co., Inc. Boston Massachusetts 02115 USA christian_fischer@merck.com., Glendorf T; Research & Early Development, Novo Nordisk A/S Måløv Denmark tgle@novonordisk.com lrli@novonordisk.com., Goldberg S; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com., Hartung IV; Medicinal Chemistry, Global R&D, Merck Healthcare KGaA Frankfurter Straße 250 64293 Darmstadt Germany ingo.hartung@merckgroup.com., Hillisch A; Research and Development, Bayer AG, Pharmaceuticals 42103 Wuppertal Germany hartmut.beck@bayer.com jan.dreher@bayer.com alexander.hillisch@bayer.com., Homan E; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet Stockholm Sweden evert.homan@ki.se maurice.grube@scilifelab.se., Knapp S; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt Frankfurt 60438 Germany knapp@pharmchem.uni-frankfurt.de tredup@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium, BMLS, Goethe University Frankfurt Frankfurt 60438 Germany susanne.mueller-knapp@bmls.de., Köster M; Boehringer Ingelheim International Binger Str. 173 D-55216 Ingelheim Germany menorca.chaturvedi@boehringer-ingelheim.com markus.koester@boehringer-ingelheim.com oliver.kraemer@boehringer-ingelheim.com., Krämer O; Boehringer Ingelheim International Binger Str. 173 D-55216 Ingelheim Germany menorca.chaturvedi@boehringer-ingelheim.com markus.koester@boehringer-ingelheim.com oliver.kraemer@boehringer-ingelheim.com., Llaveria J; A Division of Janssen-Cilag S.A., Janssen Research and Development Toledo Spain jbartolo@its.jnj.com JLlaveri@ITS.JNJ.com., Lessel U; Boehringer Ingelheim Pharma GmbH & Co. KG Birkendorfer Str. 65 D-88397 Biberach an der Riss Germany uta.lessel@boehringer-ingelheim.com., Lindemann S; Merck KGaA Darmstadt Germany ulrich.betz@merckgroup.com Sven.Lindemann@merckgroup.com., Linderoth L; Research & Early Development, Novo Nordisk A/S Måløv Denmark tgle@novonordisk.com lrli@novonordisk.com., Matsui H; Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited Fujisawa Kanagawa Japan hisanori.matsui@takeda.com., Michel M; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet Stockholm Sweden evert.homan@ki.se maurice.grube@scilifelab.se., Montel F; Boehringer Ingelheim Pharma GmbH & Co. KG Birkendorfer Str. 65 D-88397 Biberach an der Riss Germany florian.montel@boehringer-ingelheim.com., Mueller-Fahrnow A; Nuvisan Innovation Campus Berlin GmbH Müllerstraße 178 13353 Berlin Germany egner.target2035@web.de anke.mueller-fahrnow@nuvisan.com., Müller S; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt Frankfurt 60438 Germany knapp@pharmchem.uni-frankfurt.de tredup@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium, BMLS, Goethe University Frankfurt Frankfurt 60438 Germany susanne.mueller-knapp@bmls.de., Owen DR; Discovery Network Group, Pfizer Medicine Design Cambridge MA 02139 USA Dafydd.Owen@pfizer.com., Saikatendu KS; Global Research Externalization, Takeda California, Inc. 9625 Towne Center Drive San Diego CA 92121 USA kumar.saikatendu@takeda.com., Santhakumar V; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca., Sanderson W; Janssen Research & Development, Janssen Pharmaceutica N. V Beerse Belgium WSANDERS@its.jnj.com., Scholten C; Research and Development, Bayer AG, Pharmaceuticals 13353 Berlin Germany cora.scholten@bayer.com., Schapira M; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca.; Department of Pharmacology & Toxicology, University of Toronto Toronto Ontario M5S 1A8 Canada., Sharma S; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com., Shireman B; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com., Sundström M; Structural Genomics Consortium, Department of Medicine, Karolinska University Hospital and Karolinska Institutet Stockholm Sweden kristina.edfeldt@ki.se michael.sundstrom@ki.se., Todd MH; School of Pharmacy, University College London London WC1N 1AX UK mattoddchem@gmail.com., Tredup C; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt Frankfurt 60438 Germany knapp@pharmchem.uni-frankfurt.de tredup@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium, BMLS, Goethe University Frankfurt Frankfurt 60438 Germany susanne.mueller-knapp@bmls.de., Venable J; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com., Willson TM; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA tim.willson@unc.edu., Arrowsmith CH; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca.; Princess Margaret Cancer Centre Toronto Ontario M5G 1L7 Canada.
Source: RSC medicinal chemistry [RSC Med Chem] 2023 Mar 16; Vol. 14 (6), pp. 1002-1011. Date of Electronic Publication: 2023 Mar 16 (Print Publication: 2023).
Publication Type: Editorial
Journal Info: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101759460 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8682 (Electronic) Linking ISSN: 26328682 NLM ISO Abbreviation: RSC Med Chem Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37360399
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Target 2035 - an update on private sector contributions.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ackloo+S%22">Ackloo S</searchLink>; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca.<br /><searchLink fieldCode="AU" term="%22Antolin+AA%22">Antolin AA</searchLink>; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL) L'Hospitalet del Llobregat Barcelona Catalonia Spain aantolin@idibell.cat.<br /><searchLink fieldCode="AU" term="%22Bartolome+JM%22">Bartolome JM</searchLink>; A Division of Janssen-Cilag S.A., Janssen Research and Development Toledo Spain jbartolo@its.jnj.com JLlaveri@ITS.JNJ.com.<br /><searchLink fieldCode="AU" term="%22Beck+H%22">Beck H</searchLink>; Research and Development, Bayer AG, Pharmaceuticals 42103 Wuppertal Germany hartmut.beck@bayer.com jan.dreher@bayer.com alexander.hillisch@bayer.com.<br /><searchLink fieldCode="AU" term="%22Bullock+A%22">Bullock A</searchLink>; Center for Medicines Discovery, Old Road Campus, University of Oxford Roosevelt Drive, Headington Oxford OX3 7DQ UK alex.bullock@cmd.ox.ac.uk jon.elkins@cmd.ox.ac.uk.<br /><searchLink fieldCode="AU" term="%22Betz+UAK%22">Betz UAK</searchLink>; Merck KGaA Darmstadt Germany ulrich.betz@merckgroup.com Sven.Lindemann@merckgroup.com.<br /><searchLink fieldCode="AU" term="%22Böttcher+J%22">Böttcher J</searchLink>; Boehringer Ingelheim RCV GmbH & Co KG Vienna Austria jark.boettcher@boehringer-ingelheim.com.<br /><searchLink fieldCode="AU" term="%22Brown+PJ%22">Brown PJ</searchLink>; Structural Genomics Consortium, University of North Carolina at Chapel Hill USA peter.brown@unc.edu.<br /><searchLink fieldCode="AU" term="%22Chaturvedi+M%22">Chaturvedi M</searchLink>; Boehringer Ingelheim International Binger Str. 173 D-55216 Ingelheim Germany menorca.chaturvedi@boehringer-ingelheim.com markus.koester@boehringer-ingelheim.com oliver.kraemer@boehringer-ingelheim.com.<br /><searchLink fieldCode="AU" term="%22Crisp+A%22">Crisp A</searchLink>; Division of Cancer Therapeutics, The Institute of Cancer Research London SM2 5NG UK Alisa.crisp@icr.ac.uk.<br /><searchLink fieldCode="AU" term="%22Daniels+D%22">Daniels D</searchLink>; Foghorn Therapeutics 500 Technology Square, Suite 700 Cambridge MA 02139 USA DDaniels@foghorntx.com.<br /><searchLink fieldCode="AU" term="%22Dreher+J%22">Dreher J</searchLink>; Research and Development, Bayer AG, Pharmaceuticals 42103 Wuppertal Germany hartmut.beck@bayer.com jan.dreher@bayer.com alexander.hillisch@bayer.com.<br /><searchLink fieldCode="AU" term="%22Edfeldt+K%22">Edfeldt K</searchLink>; Structural Genomics Consortium, Department of Medicine, Karolinska University Hospital and Karolinska Institutet Stockholm Sweden kristina.edfeldt@ki.se michael.sundstrom@ki.se.<br /><searchLink fieldCode="AU" term="%22Edwards+AM%22">Edwards AM</searchLink>; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca.<br /><searchLink fieldCode="AU" term="%22Egner+U%22">Egner U</searchLink>; Nuvisan Innovation Campus Berlin GmbH Müllerstraße 178 13353 Berlin Germany egner.target2035@web.de anke.mueller-fahrnow@nuvisan.com.<br /><searchLink fieldCode="AU" term="%22Elkins+J%22">Elkins J</searchLink>; Center for Medicines Discovery, Old Road Campus, University of Oxford Roosevelt Drive, Headington Oxford OX3 7DQ UK alex.bullock@cmd.ox.ac.uk jon.elkins@cmd.ox.ac.uk.<br /><searchLink fieldCode="AU" term="%22Fischer+C%22">Fischer C</searchLink>; Discovery Chemistry, Merck & Co., Inc. Boston Massachusetts 02115 USA christian_fischer@merck.com.<br /><searchLink fieldCode="AU" term="%22Glendorf+T%22">Glendorf T</searchLink>; Research & Early Development, Novo Nordisk A/S Måløv Denmark tgle@novonordisk.com lrli@novonordisk.com.<br /><searchLink fieldCode="AU" term="%22Goldberg+S%22">Goldberg S</searchLink>; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Hartung+IV%22">Hartung IV</searchLink>; Medicinal Chemistry, Global R&D, Merck Healthcare KGaA Frankfurter Straße 250 64293 Darmstadt Germany ingo.hartung@merckgroup.com.<br /><searchLink fieldCode="AU" term="%22Hillisch+A%22">Hillisch A</searchLink>; Research and Development, Bayer AG, Pharmaceuticals 42103 Wuppertal Germany hartmut.beck@bayer.com jan.dreher@bayer.com alexander.hillisch@bayer.com.<br /><searchLink fieldCode="AU" term="%22Homan+E%22">Homan E</searchLink>; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet Stockholm Sweden evert.homan@ki.se maurice.grube@scilifelab.se.<br /><searchLink fieldCode="AU" term="%22Knapp+S%22">Knapp S</searchLink>; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt Frankfurt 60438 Germany knapp@pharmchem.uni-frankfurt.de tredup@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium, BMLS, Goethe University Frankfurt Frankfurt 60438 Germany susanne.mueller-knapp@bmls.de.<br /><searchLink fieldCode="AU" term="%22Köster+M%22">Köster M</searchLink>; Boehringer Ingelheim International Binger Str. 173 D-55216 Ingelheim Germany menorca.chaturvedi@boehringer-ingelheim.com markus.koester@boehringer-ingelheim.com oliver.kraemer@boehringer-ingelheim.com.<br /><searchLink fieldCode="AU" term="%22Krämer+O%22">Krämer O</searchLink>; Boehringer Ingelheim International Binger Str. 173 D-55216 Ingelheim Germany menorca.chaturvedi@boehringer-ingelheim.com markus.koester@boehringer-ingelheim.com oliver.kraemer@boehringer-ingelheim.com.<br /><searchLink fieldCode="AU" term="%22Llaveria+J%22">Llaveria J</searchLink>; A Division of Janssen-Cilag S.A., Janssen Research and Development Toledo Spain jbartolo@its.jnj.com JLlaveri@ITS.JNJ.com.<br /><searchLink fieldCode="AU" term="%22Lessel+U%22">Lessel U</searchLink>; Boehringer Ingelheim Pharma GmbH & Co. KG Birkendorfer Str. 65 D-88397 Biberach an der Riss Germany uta.lessel@boehringer-ingelheim.com.<br /><searchLink fieldCode="AU" term="%22Lindemann+S%22">Lindemann S</searchLink>; Merck KGaA Darmstadt Germany ulrich.betz@merckgroup.com Sven.Lindemann@merckgroup.com.<br /><searchLink fieldCode="AU" term="%22Linderoth+L%22">Linderoth L</searchLink>; Research & Early Development, Novo Nordisk A/S Måløv Denmark tgle@novonordisk.com lrli@novonordisk.com.<br /><searchLink fieldCode="AU" term="%22Matsui+H%22">Matsui H</searchLink>; Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited Fujisawa Kanagawa Japan hisanori.matsui@takeda.com.<br /><searchLink fieldCode="AU" term="%22Michel+M%22">Michel M</searchLink>; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet Stockholm Sweden evert.homan@ki.se maurice.grube@scilifelab.se.<br /><searchLink fieldCode="AU" term="%22Montel+F%22">Montel F</searchLink>; Boehringer Ingelheim Pharma GmbH & Co. KG Birkendorfer Str. 65 D-88397 Biberach an der Riss Germany florian.montel@boehringer-ingelheim.com.<br /><searchLink fieldCode="AU" term="%22Mueller-Fahrnow+A%22">Mueller-Fahrnow A</searchLink>; Nuvisan Innovation Campus Berlin GmbH Müllerstraße 178 13353 Berlin Germany egner.target2035@web.de anke.mueller-fahrnow@nuvisan.com.<br /><searchLink fieldCode="AU" term="%22Müller+S%22">Müller S</searchLink>; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt Frankfurt 60438 Germany knapp@pharmchem.uni-frankfurt.de tredup@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium, BMLS, Goethe University Frankfurt Frankfurt 60438 Germany susanne.mueller-knapp@bmls.de.<br /><searchLink fieldCode="AU" term="%22Owen+DR%22">Owen DR</searchLink>; Discovery Network Group, Pfizer Medicine Design Cambridge MA 02139 USA Dafydd.Owen@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Saikatendu+KS%22">Saikatendu KS</searchLink>; Global Research Externalization, Takeda California, Inc. 9625 Towne Center Drive San Diego CA 92121 USA kumar.saikatendu@takeda.com.<br /><searchLink fieldCode="AU" term="%22Santhakumar+V%22">Santhakumar V</searchLink>; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca.<br /><searchLink fieldCode="AU" term="%22Sanderson+W%22">Sanderson W</searchLink>; Janssen Research & Development, Janssen Pharmaceutica N. V Beerse Belgium WSANDERS@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Scholten+C%22">Scholten C</searchLink>; Research and Development, Bayer AG, Pharmaceuticals 13353 Berlin Germany cora.scholten@bayer.com.<br /><searchLink fieldCode="AU" term="%22Schapira+M%22">Schapira M</searchLink>; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca.; Department of Pharmacology & Toxicology, University of Toronto Toronto Ontario M5S 1A8 Canada.<br /><searchLink fieldCode="AU" term="%22Sharma+S%22">Sharma S</searchLink>; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Shireman+B%22">Shireman B</searchLink>; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Sundström+M%22">Sundström M</searchLink>; Structural Genomics Consortium, Department of Medicine, Karolinska University Hospital and Karolinska Institutet Stockholm Sweden kristina.edfeldt@ki.se michael.sundstrom@ki.se.<br /><searchLink fieldCode="AU" term="%22Todd+MH%22">Todd MH</searchLink>; School of Pharmacy, University College London London WC1N 1AX UK mattoddchem@gmail.com.<br /><searchLink fieldCode="AU" term="%22Tredup+C%22">Tredup C</searchLink>; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt Frankfurt 60438 Germany knapp@pharmchem.uni-frankfurt.de tredup@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium, BMLS, Goethe University Frankfurt Frankfurt 60438 Germany susanne.mueller-knapp@bmls.de.<br /><searchLink fieldCode="AU" term="%22Venable+J%22">Venable J</searchLink>; Janssen Research and Development LLC San Diego California USA SGoldbe1@its.jnj.com ssharm505@ITS.JNJ.com BShirema@its.jnj.com JVenable@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Willson+TM%22">Willson TM</searchLink>; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA tim.willson@unc.edu.<br /><searchLink fieldCode="AU" term="%22Arrowsmith+CH%22">Arrowsmith CH</searchLink>; Structural Genomics Consortium, University of Toronto Toronto Ontario M5G 1L7 Canada suzanne.ackloo@utoronto.ca aled.edwards@utoronto.ca Cheryl.Arrowsmith@uhnresearch.ca.; Princess Margaret Cancer Centre Toronto Ontario M5G 1L7 Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101759460%22">RSC medicinal chemistry</searchLink> [RSC Med Chem] 2023 Mar 16; Vol. 14 (6), pp. 1002-1011. <i>Date of Electronic Publication: </i>2023 Mar 16 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Royal+Society+of+Chemistry%22">Royal Society of Chemistry </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101759460 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-8682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226328682%22">26328682 </searchLink><i>NLM ISO Abbreviation: </i>RSC Med Chem <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37360399
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1039/d2md00441k
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1002
    Titles:
      – TitleFull: Target 2035 - an update on private sector contributions.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ackloo S
      – PersonEntity:
          Name:
            NameFull: Antolin AA
      – PersonEntity:
          Name:
            NameFull: Bartolome JM
      – PersonEntity:
          Name:
            NameFull: Beck H
      – PersonEntity:
          Name:
            NameFull: Bullock A
      – PersonEntity:
          Name:
            NameFull: Betz UAK
      – PersonEntity:
          Name:
            NameFull: Böttcher J
      – PersonEntity:
          Name:
            NameFull: Brown PJ
      – PersonEntity:
          Name:
            NameFull: Chaturvedi M
      – PersonEntity:
          Name:
            NameFull: Crisp A
      – PersonEntity:
          Name:
            NameFull: Daniels D
      – PersonEntity:
          Name:
            NameFull: Dreher J
      – PersonEntity:
          Name:
            NameFull: Edfeldt K
      – PersonEntity:
          Name:
            NameFull: Edwards AM
      – PersonEntity:
          Name:
            NameFull: Egner U
      – PersonEntity:
          Name:
            NameFull: Elkins J
      – PersonEntity:
          Name:
            NameFull: Fischer C
      – PersonEntity:
          Name:
            NameFull: Glendorf T
      – PersonEntity:
          Name:
            NameFull: Goldberg S
      – PersonEntity:
          Name:
            NameFull: Hartung IV
      – PersonEntity:
          Name:
            NameFull: Hillisch A
      – PersonEntity:
          Name:
            NameFull: Homan E
      – PersonEntity:
          Name:
            NameFull: Knapp S
      – PersonEntity:
          Name:
            NameFull: Köster M
      – PersonEntity:
          Name:
            NameFull: Krämer O
      – PersonEntity:
          Name:
            NameFull: Llaveria J
      – PersonEntity:
          Name:
            NameFull: Lessel U
      – PersonEntity:
          Name:
            NameFull: Lindemann S
      – PersonEntity:
          Name:
            NameFull: Linderoth L
      – PersonEntity:
          Name:
            NameFull: Matsui H
      – PersonEntity:
          Name:
            NameFull: Michel M
      – PersonEntity:
          Name:
            NameFull: Montel F
      – PersonEntity:
          Name:
            NameFull: Mueller-Fahrnow A
      – PersonEntity:
          Name:
            NameFull: Müller S
      – PersonEntity:
          Name:
            NameFull: Owen DR
      – PersonEntity:
          Name:
            NameFull: Saikatendu KS
      – PersonEntity:
          Name:
            NameFull: Santhakumar V
      – PersonEntity:
          Name:
            NameFull: Sanderson W
      – PersonEntity:
          Name:
            NameFull: Scholten C
      – PersonEntity:
          Name:
            NameFull: Schapira M
      – PersonEntity:
          Name:
            NameFull: Sharma S
      – PersonEntity:
          Name:
            NameFull: Shireman B
      – PersonEntity:
          Name:
            NameFull: Sundström M
      – PersonEntity:
          Name:
            NameFull: Todd MH
      – PersonEntity:
          Name:
            NameFull: Tredup C
      – PersonEntity:
          Name:
            NameFull: Venable J
      – PersonEntity:
          Name:
            NameFull: Willson TM
      – PersonEntity:
          Name:
            NameFull: Arrowsmith CH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 03
              Text: 2023 Mar 16
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2632-8682
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: RSC medicinal chemistry
              Type: main
ResultId 1